News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cyclopharm.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Cyclopharm sends reply to FDA, the final step before potential approval
News
Market highlights and 5 ASX small caps to watch on Wednesday
Health & Biotech
ASX Health Stocks: FDA to expedite submission for Botanix’s sweaty armpits gel
Health & Biotech
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit
Health & Biotech
Check Up: Johnson & Johnson manoeuvre causes a stir, as CSL pulls Healthcare higher on the ASX
Health & Biotech
ASX Health Stocks: Clinical trials gather pace for Visioneering Tech, Anteris and other biotechs
Health & Biotech
ASX Health Stocks: IDT shoots 20pc on COVID-19 deal with government, ImpediMed granted US FDA Breakthrough
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Health & Biotech
ASX health stocks: EMV’s brain scanner is completed and ready for testing, stock price jumps 16pc
News
Market Highlights and 5 ASX Small Caps to watch on Friday
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Who left something behind today?
Health & Biotech
Cyclopharm shares plunge after FDA delays Technegas approval
News
10 at 10: These ASX stocks are steaming ahead this morning
Health & Biotech
Medical devices tracker: All the life-saving gadgets ASX companies are working on right now
Health & Biotech
TGA approves Pfizer jab; Nyrada, Mach7 hit all-time high
News